{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:21:55Z","timestamp":1770826915091,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1479-5876-9-194","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T03:13:01Z","timestamp":1322881981000},"source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies"],"prefix":"10.1186","volume":"9","author":[{"given":"Usman A","family":"Ashfaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Z","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Tariq","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"944_CR1","first-page":"4","volume":"41","author":"NS Raja","year":"2008","unstructured":"Raja NS, Janjua NK: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect. 2008, 41: 4-8.","journal-title":"J Microbiol Immunol Infect"},{"key":"944_CR2","first-page":"1253","volume-title":"Fields Virology","author":"SM Lemon","year":"2007","unstructured":"Lemon SM, Walker C, Alter MJ, Yi M: Hepatitis Cvirus. Fields Virology. Edited by: Knipe DM, Howley PM. 2007, 1253-1304."},{"key":"944_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Hoofnagle JH: Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005, 436: 967-972. 10.1038\/nature04082.","journal-title":"Nature"},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nature04080","volume":"436","author":"R De Francesco","year":"2005","unstructured":"De Francesco R, Migliaccio G: Challenges and successes in developing new therapies for hepatitis C. Nature. 2005, 436: 953-960. 10.1038\/nature04080.","journal-title":"Nature"},{"key":"944_CR5","first-page":"838","volume":"5","author":"PL Beaulieu","year":"2004","unstructured":"Beaulieu PL, Tsantrizos YS: Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs. 2004, 5: 838-850.","journal-title":"Curr Opin Investig Drugs"},{"key":"944_CR6","doi-asserted-by":"publisher","first-page":"e2660","DOI":"10.1371\/journal.pone.0002660","volume":"3","author":"M Buck","year":"2008","unstructured":"Buck M: Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One. 2008, 3: e2660-10.1371\/journal.pone.0002660.","journal-title":"PLoS One"},{"key":"944_CR7","first-page":"4836","volume":"12","author":"MK el-Awady","year":"2006","unstructured":"el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, Bader el-Din NG, Redwan el RM, el-Demellawy M, Omran MH: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol. 2006, 12: 4836-4842.","journal-title":"World J Gastroenterol"},{"key":"944_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2353\/ajpath.2007.060789","volume":"170","author":"CA Lazaro","year":"2007","unstructured":"Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N: Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol. 2007, 170: 478-489. 10.2353\/ajpath.2007.060789.","journal-title":"Am J Pathol"},{"key":"944_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/JVI.01443-07","volume":"82","author":"S Molina","year":"2008","unstructured":"Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, Sacunha A, Larrey D: Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol. 2008, 82: 569-574. 10.1128\/JVI.01443-07.","journal-title":"J Virol"},{"key":"944_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"197","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Dubuisson J, Cosset FL: Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med. 2003, 197: 633-642. 10.1084\/jem.20021756.","journal-title":"J Exp Med"},{"key":"944_CR11","doi-asserted-by":"publisher","first-page":"41624","DOI":"10.1074\/jbc.M305289200","volume":"278","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A, Cosset FL: Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem. 2003, 278: 41624-41630. 10.1074\/jbc.M305289200.","journal-title":"J Biol Chem"},{"key":"944_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","volume":"546","author":"HE Drummer","year":"2003","unstructured":"Drummer HE, Maerz A, Poumbourios P: Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 2003, 546: 385-390. 10.1016\/S0014-5793(03)00635-5.","journal-title":"FEBS Lett"},{"key":"944_CR13","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","volume":"79","author":"A Goffard","year":"2005","unstructured":"Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J: Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol. 2005, 79: 8400-8409. 10.1128\/JVI.79.13.8400-8409.2005.","journal-title":"J Virol"},{"key":"944_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.immunol.16.1.89","volume":"16","author":"S Levy","year":"1998","unstructured":"Levy S, Todd SC, Maecker HT: CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol. 1998, 16: 89-109. 10.1146\/annurev.immunol.16.1.89.","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"944_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/10428199409052677","volume":"13","author":"P Engel","year":"1994","unstructured":"Engel P, Tedder TF: New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk Lymphoma. 1994, 13 (Suppl 1): 61-64.","journal-title":"Leuk Lymphoma"},{"key":"944_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/AAC.01081-08","volume":"53","author":"M Flint","year":"2009","unstructured":"Flint M, Mullen S, Deatly AM, Chen W, Miller LZ, Ralston R, Broom C, Emini EA, Howe AY: Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034). Antimicrob Agents Chemother. 2009, 53: 401-411. 10.1128\/AAC.01081-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"944_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S: Binding of hepatitis C virus to CD81. Science. 1998, 282: 938-941.","journal-title":"Science"},{"key":"944_CR18","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A: The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo J. 2002, 21: 5017-5025. 10.1093\/emboj\/cdf529.","journal-title":"Embo J"},{"key":"944_CR19","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","volume":"100","author":"M Hsu","year":"2003","unstructured":"Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA: Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA. 2003, 100: 7271-7276. 10.1073\/pnas.0832180100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"944_CR20","first-page":"727","volume":"7","author":"NA Meanwell","year":"2006","unstructured":"Meanwell NA: Hepatitis C virus entry: an intriguing challenge for drug discovery. Curr Opin Investig Drugs. 2006, 7: 727-732.","journal-title":"Curr Opin Investig Drugs"},{"key":"944_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1743-422X-8-248","volume":"8","author":"UA Ashfaq","year":"2011","unstructured":"Ashfaq UA, Masoud MS, Khaliq S, Nawaz Z, Riazuddin S: Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin. Virology J. 2011, 8: 248-10.1186\/1743-422X-8-248.","journal-title":"Virology J"},{"key":"944_CR22","doi-asserted-by":"publisher","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","volume":"79","author":"A Owsianka","year":"2005","unstructured":"Owsianka A, Tarr AW, Juttla VS, Lavillette D, Bartosch B, Cosset FL, Ball JK, Patel AH: Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol. 2005, 79: 11095-11104. 10.1128\/JVI.79.17.11095-11104.2005.","journal-title":"J Virol"},{"key":"944_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm1698","volume":"14","author":"M Law","year":"2008","unstructured":"Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI: Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med. 2008, 14: 25-27. 10.1038\/nm1698.","journal-title":"Nat Med"},{"key":"944_CR24","doi-asserted-by":"publisher","first-page":"7705","DOI":"10.1073\/pnas.0402458101","volume":"101","author":"MY Yu","year":"2004","unstructured":"Yu MY, Bartosch B, Zhang P, Guo ZP, Renzi PM, Shen LM, Granier C, Feinstone SM, Cosset FL, Purcell RH: Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc Natl Acad Sci USA. 2004, 101: 7705-7710. 10.1073\/pnas.0402458101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"944_CR25","doi-asserted-by":"publisher","first-page":"12473","DOI":"10.1128\/JVI.01138-09","volume":"83","author":"TJ Broering","year":"2009","unstructured":"Broering TJ, Garrity KA, Boatright NK, Sloan SE, Sandor F, Thomas WD, Szabo G, Finberg RW, Ambrosino DM, Babcock GJ: Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J Virol. 2009, 83: 12473-12482. 10.1128\/JVI.01138-09.","journal-title":"J Virol"},{"key":"944_CR26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/hep.20906","volume":"42","author":"DJ Schofield","year":"2005","unstructured":"Schofield DJ, Bartosch B, Shimizu YK, Allander T, Alter HJ, Emerson SU, Cosset FL, Purcell RH: Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity. Hepatology. 2005, 42: 1055-1062. 10.1002\/hep.20906.","journal-title":"Hepatology"},{"key":"944_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/viro.1998.9202","volume":"249","author":"F Habersetzer","year":"1998","unstructured":"Habersetzer F, Fournillier A, Dubuisson J, Rosa D, Abrignani S, Wychowski C, Nakano I, Trepo C, Desgranges C, Inchauspe G: Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology. 1998, 249: 32-41. 10.1006\/viro.1998.9202.","journal-title":"Virology"},{"key":"944_CR28","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1128\/JVI.78.3.1448-1455.2004","volume":"78","author":"J Zhang","year":"2004","unstructured":"Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA: CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol. 2004, 78: 1448-1455. 10.1128\/JVI.78.3.1448-1455.2004.","journal-title":"J Virol"},{"key":"944_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/hep.20542","volume":"41","author":"D Lavillette","year":"2005","unstructured":"Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, Bain C, Patel AH, Dubuisson J, Ball JK, Cosset FL: Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology. 2005, 41: 265-274. 10.1002\/hep.20542.","journal-title":"Hepatology"},{"key":"944_CR30","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1073\/pnas.0402253101","volume":"101","author":"EG Cormier","year":"2004","unstructured":"Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T: CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA. 2004, 101: 7270-7274. 10.1073\/pnas.0402253101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"944_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/JVI.01134-06","volume":"81","author":"SB Kapadia","year":"2007","unstructured":"Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV: Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol. 2007, 81: 374-383. 10.1128\/JVI.01134-06.","journal-title":"J Virol"},{"key":"944_CR32","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1128\/JVI.02460-05","volume":"80","author":"G Koutsoudakis","year":"2006","unstructured":"Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R: Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol. 2006, 80: 5308-5320. 10.1128\/JVI.02460-05.","journal-title":"J Virol"},{"key":"944_CR33","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1128\/JVI.75.12.5550-5558.2001","volume":"75","author":"NH Gruener","year":"2001","unstructured":"Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR, Klenerman P: Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol. 2001, 75: 5550-5558. 10.1128\/JVI.75.12.5550-5558.2001.","journal-title":"J Virol"},{"key":"944_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2005.12.027","volume":"348","author":"B Bartosch","year":"2006","unstructured":"Bartosch B, Cosset FL: Cell entry of hepatitis C virus. Virology. 2006, 348: 1-12. 10.1016\/j.virol.2005.12.027.","journal-title":"Virology"},{"key":"944_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.chembiol.2005.10.006","volume":"13","author":"B Rakic","year":"2006","unstructured":"Rakic B, Sagan SM, Noestheden M, Belanger S, Nan X, Evans CL, Xie XS, Pezacki JP: Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication. Chem Biol. 2006, 13: 23-30. 10.1016\/j.chembiol.2005.10.006.","journal-title":"Chem Biol"},{"key":"944_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999, 285: 110-113. 10.1126\/science.285.5424.110.","journal-title":"Science"},{"key":"944_CR37","doi-asserted-by":"crossref","unstructured":"Cheng Y, Tsou LK, Cai J, Aya T, Dutschman GE, Gullen EA, Grill SP, Chen AP, Lindenbach BD, Hamilton AD, Cheng YC: A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro. Antimicrob Agents Chemother. 54: 197-206.","DOI":"10.1128\/AAC.01206-09"},{"key":"944_CR38","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA. 2005, 102: 9294-9299. 10.1073\/pnas.0503596102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"944_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/laban0205-39","volume":"34","author":"C Guha","year":"2005","unstructured":"Guha C, Lee SW, Chowdhury NR, Chowdhury JR: Cell culture models and animal models of viral hepatitis. Part II: hepatitis C. Lab Anim (NY). 2005, 34: 39-47.","journal-title":"Lab Anim (NY)"},{"key":"944_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-422X-6-13","volume":"6","author":"AR Zekri","year":"2009","unstructured":"Zekri AR, Bahnassy AA, El-Din HM, Salama HM: Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J. 2009, 6: 13-10.1186\/1743-422X-6-13.","journal-title":"Virol J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-9-194\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T18:30:06Z","timestamp":1548181806000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-194","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]},"article-number":"194"}}